{"id":7897,"date":"2020-08-24T12:24:51","date_gmt":"2020-08-24T12:24:51","guid":{"rendered":"https:\/\/heliospectra.com\/blog\/mfn_news\/vastra-hamnen-heliospectra-pandemic-taking-its-toll\/"},"modified":"2025-04-09T17:39:30","modified_gmt":"2025-04-09T17:39:30","slug":"vastra-hamnen-heliospectra-pandemic-taking-its-toll","status":"publish","type":"mfn_news","link":"https:\/\/heliospectra.com\/blog\/mfn_news\/vastra-hamnen-heliospectra-pandemic-taking-its-toll\/","title":{"rendered":"V\u00e4stra Hamnen:\u00a0Heliospectra –\u00a0Pandemic taking its toll"},"content":{"rendered":"
<\/p>\n

Västra Hamnen Corporate Finance has released a research update on Heliospectra AB following the company’s report for Q2 2020. The pandemic has caused among the lowest sales and order figures for years and another capital injection might be unavoidable. We lower our valuation interval to SEK 5.00 – 7.50 per share, writes Västra Hamnen.
 <\/p>\n

<\/strong><\/div>\n